DYSTROPHIC EPIDERMOLYSIS BULLOSA
Clinical trials for DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New topical therapy trial offers hope for 'Butterfly Skin' wound healing
Disease control Recruiting nowThis early-stage clinical trial is testing whether a topical gel called EV.FV can help heal wounds in people with dystrophic epidermolysis bullosa, a severe genetic skin condition. The treatment uses tiny particles from stem cells to deliver healing signals directly to the skin. …
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: Isfahan University of Medical Sciences • Aim: Disease control
Last updated Apr 02, 2026 05:42 UTC
-
New combo therapy aims to heal fragile skin
Disease control Recruiting nowThis study is testing if adding an IV immunoglobulin (IV IgG) treatment to an existing gene therapy (VYJUVEK) helps wounds heal better in people with Recessive Dystrophic Epidermolysis Bullosa (RDEB), a severe genetic skin condition. The main goal is to see if this combination re…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New eye drop aims to soothe painful scratches in rare skin disorder
Disease control Recruiting nowThis study is testing whether an investigational eye drop called KB803 can safely reduce the frequency and pain of corneal abrasions (scratches on the eye's surface) in people with dystrophic epidermolysis bullosa (DEB), a rare genetic skin condition. Participants, including chil…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New gel tested to heal fragile skin in 'Butterfly Children' disease
Disease control Recruiting nowThis study is testing a gel called TCP-25 to see if it can help heal skin wounds in people with Epidermolysis Bullosa (EB), a rare condition that causes extremely fragile skin. Researchers will compare the gel to a placebo (vehicle) gel by applying each to a different matching wo…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE2 • Sponsor: Xinnate AB • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC